Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbbVie Inc (ABBV) vs Western Digital Corp (WDC) Price & Performance

AbbVie IncTrade
Western Digital CorpTrade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs Western Digital Corp — how do they compare? AbbVie Inc trades at $250.35 (market cap $438.19B), while Western Digital Corp trades at $444.92 (market cap $151.09B). The key difference: AbbVie Inc is far larger — about 2.9× Western Digital Corp's market cap, and AbbVie Inc pays the higher dividend (2.79%). Which is the better fit depends on your goals.

ABBVWDC
Market Cap
$438.19B$151.09B
Sector
HealthTechnology
52-Week High
$263.58$746.23
52-Week Low
$197.38$74.66
Enterprise Value
$502.45B$150.56B
Dividend Yield
2.79%0.14%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

AbbVie (ABBV) trades at $247.91, up 0.76% on the day, with strong technical momentum as the stock approaches resistance near $249. The company demonstrates solid fundamentals with Q2 2026 EPS beating expectations at $3.65 versus $3.61, driven by robust immunology portfolio growth from Skyrizi and Rinvoq offsetting Humira declines. Revenue reached $61.16B in 2025 with a 71.48% gross margin, though net income margin compressed to 9.8%. Recent positive Phase 2 ovarian cancer data and institutional accumulation signal confidence in the pipeline.

Outlook remains positive with analyst consensus target of $281.33 (13.5% upside) and 71% buy ratings, though elevated P/E of 70.05 reflects growth expectations. Key risks include patent cliffs in the 2030s, competitive pressures, and regulatory uncertainties from drug pricing lawsuits. The dividend aristocrat offers income stability with recent $1.73 payout, but investors should monitor execution of oncology pipeline and debt levels at 50.4% of assets.

Western Digital Corp

WDC trades at $434.3, down 3.81% over 24 hours, with a bearish technical signal as it hovers near the pivot point of $440. The company has shown strong earnings beats in recent quarters, with Q2 2026 EPS of $3.56 surpassing the $3.31 estimate, and maintains robust profitability margins, including a net income margin of 72.95% for 2025. Revenue for 2025 was $9.52B, with a significant turnaround to net income of $1.86B from prior losses, indicating operational recovery amid high cloud demand.

The outlook is mixed, with analyst consensus strongly bullish (72.13% buy ratings) and a price target of $665.15 suggesting substantial upside, but risks include high valuation multiples like a P/E of 17.89 and EV/EBITDA of 29.99, competitive pressures in HDD storage, and recent post-earnings sell-offs due to margin concerns. Investors should weigh the growth potential from AI-driven storage demand against cyclical and valuation headwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Read more on ABBV

About Western Digital Corp

Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.

Read more on WDC